Lost password ?
UNIMED, WORTH MORE THAN JUST A GLANCE
Jan 20 - The Pharma sector covered by AlphaMena (6 stocks, €428m market cap) continues to lose ground, dropping by more than 42% over the last year. The current fundamental potential ...
Executive summary
Conflict of Interest
Pages 2
Language English
Publish on January 20, 2020
€ 500
VAT Exl.
You might be also interested by these reports :
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.